Retinal Vasculitis Secondary to Durvalumab

Andrade, AR; Moll-Udina, A; Martin, R; Cilveti, E; Subira, O; Disfetano, L; Garcia-Arumi, J

CASE REPORTS IN OPHTHALMOLOGY, 2020; 11 (2): 161

Abstract

Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment......

Full Text Link